🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective descriptive and pharmacokinetic study will be conduct...
Status
Completed
Location
Shoklo Malaria Research Unit
Start Date
2015-07-07
Trial ID
NCT02457208
Treatments Being Tested
The 4-month daily regimen containing moxifloxacin (2HRZEM 7 / 2HRM7) of ICM...
Status
Unknown
Location
National Institute for Research in Tuberculosis
Start Date
2022-03-15
Trial ID
NCT05047055
Treatments Being Tested
A phase 2, two-part, multicentre, open label, controlled, randomised clinic...
Status
Not Yet Recruiting
Location
TASK Brooklyn
Start Date
2026-07-23
Trial ID
NCT07773610
DATURA trial is a phase III, multicenter, two-arm, open-label, randomized s...
Status
Completed
Location
National Center for HIV/AIDS, Dermatology and STD (NCHADS)
Start Date
2022-04-21
Trial ID
NCT04738812
Treatments Being Tested
Tuberculosis (TB) patients often have a lower body mass index (BMI) and exp...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT02554318
Treatments Being Tested
The purpose of this study is to assess pharmacokinetic parameters of atorva...
Status
Recruiting
Location
National Tuberculosis and Leprosy Training Centre, Saye
Start Date
2026-01-03
Trial ID
NCT07303699
Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Status
Recruiting
Location
National Tuberculosis Reference Laboratory
Start Date
2024-01-03
Trial ID
NCT06199921
The purpose of this study is to assess the safety, early bactericidal activ...
Status
Completed
Location
TASK
Start Date
2020-01-16
Trial ID
NCT04176250
The goal of this clinical trial is to evaluate 3 dose levels of TBAJ876 for...
Status
Active Not Recruiting
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2023-10-31
Trial ID
NCT06058299
Treatments Being Tested